Clinical Trial Update: Bevacizumab Plus Fluorouracil and Leucovorin in Treating Patients With Locally Advanced or Metastatic Stage IV Colorectal Cancer That Has Progressed After Standard Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bevacizumab with fluorouracil and leucovorin in patients with locally advanced or metastatic stage IV colorectal cancer that progressed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED